FDA okays start of BrainStorm stem cell trial in ALS patients – WTAQ
FDA okays start of BrainStorm stem cell trial in ALS patientsWTAQTEL AVIV (Reuters) – BrainStorm Cell Therapeutics said the U.S. Food and Drug Administration approved the start of a mid-stage clinical trial of its adult stem cell treatment for patients with amyotrophic lateral sclerosis (ALS). The Phase II trial … and more …read more &nbs… Continue reading
